antiparkinsonian

antiparkinsonian

 [an″te-, an″ti-pahr″kin-so´ne-an]
1. effective in treatment of parkinsonism.
2. an agent that has this property.

antiparkinsonian

(ant″i-par″kĭn-sō′nē-ăn) [ anti- + parkinsonian]
1. Effective against parkinsonism.
2. An agent effective against parkinsonism.
References in periodicals archive ?
Co-prescription pattern of other drugs showed that 77% mood stabilizers, 56% antidepressants, 57.5% anxiolytics, 7% hypnotics and 65% antiparkinsonian drugs are being given to the patients on top with antipsychotics.
People with Parkinson's disease from both genders were included, who presented clinic diagnosis of idiopathic Parkinson's disease in phases 1 to 3, as established by the world scale for classifying the disease, Hoehn and Yahr (12), and people on the "on" phase, that is, under the influence of antiparkinsonian drugs, possessing at least six natural front teeth or dental prosthesis that filled in the missing ones on both dental arches.
It has been found that psychotic symptoms occur in less than 10% of PD patients who do not use antiparkinsonian agents [7-10].
[10] OH may be the result of underlying cardiovascular autonomic dysfunction or adverse effect of antiparkinsonian drugs.
Alterations of pathophysiological mechanisms are thought to underlie several processes, including sleep-wake regulatory centers, overnight emergence of motor symptoms, adverse effects of antiparkinsonian medications, psychiatric symptoms, and sleep fragmentation caused by multiple factors.[1],[2] However, recent genetic studies of PD had identified multiple genes and loci which might be associated with sleep disorders.
Gender, CDR, clinical features, clinical history of VRFs, current use of antipsychotics, and current use of antiparkinsonian drugs were analyzed using the chi-square test.
The following inclusion criteria applied: (1) participants diagnosed with idiopathic PD in accordance with the UK PD Brain Bank criteria, (2) presence of MCI in accordance with the Movement Disorder Society (MDS) PD-MCI Level II diagnostic criteria [13], (3) a stable response to antiparkinsonian medication at pre-intervention and during the course of the intervention, and (4) cognitive deficits that did not interfere with functional independence (i.e., UPDRS-II score less than 3).
Also, some of new compounds containing the nitrogen atom have been synthesized and used as antihypertensive [alpha]-blocking [3], antiparkinsonian [4], antialzheimer [5], antimicrobial [6-8], and anti-inflammatory [9, 10] agents.
Conversely, comparatively few studies have been dedicated to the pharmacology of antiparkinsonian drugs [38, 39] and the actions of ropinirole and pramipexole at hiPSCs differentiated into DA neurons have never, to our knowledge, been investigated.
Indeed, in rodent models of PD, A2A antagonism exerts antiparkinsonian actions [162-164].
(42) looked at 24 elderly PD subjects that used at least one antiparkinsonian drug (either levodopa, pramipexole, amantadine or biperiden).